CALCIUM CHLORIDE

CALCIUM CHLORIDE was reported 31090 times

CALCIUM CHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFUSION SITE ISCHAEMIA 3 0.5000
1 MECHANICAL VENTILATION COMPLICATION 24 0.1611
2 LUPUS VULGARIS 139 0.1103
3 INSPIRATORY CAPACITY DECREASED 24 0.0866
4 BURKHOLDERIA TEST POSITIVE 9 0.0726
5 ENTHESOPHYTE 3 0.0714
6 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 46 0.0689
7 CARCINOID TUMOUR OF THE SMALL BOWEL 7 0.0673
8 GENITAL EROSION 19 0.0640
9 GASTROINTESTINAL DILATION PROCEDURE 3 0.0638
10 APPENDICOLITH 21 0.0543
11 DEEP VEIN THROMBOSIS POSTOPERATIVE 107 0.0534
12 BACTEROIDES INFECTION 13 0.0498
13 BACILLUS BACTERAEMIA 5 0.0459
14 HYPOCHOLESTEROLAEMIA 14 0.0397
15 RENAL ISCHAEMIA 18 0.0329
16 SLEEP DISORDER THERAPY 6 0.0303
17 TRANSFUSION-RELATED CIRCULATORY OVERLOAD 7 0.0289
18 ULCER HAEMORRHAGE 192 0.0283
19 SWOLLEN JOINT COUNT INCREASED 89 0.0279
20 PO2 INCREASED 14 0.0276
21 EYE INJURY 83 0.0273
22 PCO2 INCREASED 18 0.0253
23 C-REACTIVE PROTEIN 23 0.0248
24 INTRADUCTAL PAPILLOMA OF BREAST 3 0.0234
25 RECURRENCE OF NEUROMUSCULAR BLOCKADE 4 0.0234
26 RHEUMATIC FEVER 103 0.0231
27 ANALGESIC THERAPY 7 0.0218
28 ADENOMATOUS POLYPOSIS COLI 3 0.0213
29 DRUG THERAPY 7 0.0206
30 TOTAL LUNG CAPACITY ABNORMAL 8 0.0206
31 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 39 0.0188
32 PEMPHIGUS 230 0.0184
33 RHEUMATOID FACTOR POSITIVE 105 0.0182
34 DRUG TOLERANCE DECREASED 50 0.0178
35 MUCOSAL EROSION 16 0.0176
36 ORAL PUSTULE 4 0.0172
37 DISLOCATION OF VERTEBRA 39 0.0171
38 MUSCLE INJURY 140 0.0169
39 PULMONARY VASCULITIS 9 0.0167
40 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 111 0.0155
41 DUODENAL ULCER PERFORATION 115 0.0154
42 SPIROMETRY ABNORMAL 9 0.0151
43 THORACIC CAVITY DRAINAGE 4 0.0150
44 MITE ALLERGY 9 0.0137
45 DIABETES INSIPIDUS 32 0.0133
46 SERONEGATIVE ARTHRITIS 15 0.0131
47 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 80 0.0123
48 HELICOBACTER INFECTION 126 0.0122
49 FACET JOINT SYNDROME 39 0.0120
50 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 11 0.0119
51 HAEMOPERITONEUM 9 0.0112
52 PERICARDITIS 188 0.0112
53 X-RAY ABNORMAL 20 0.0112
54 JOINT DESTRUCTION 17 0.0109
55 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 8 0.0109
56 MYCOTIC ALLERGY 9 0.0105
57 ADMINISTRATION SITE ERYTHEMA 3 0.0105
58 BLOOD PH DECREASED 18 0.0105
59 FOLLICULITIS 108 0.0103
60 NECROTISING COLITIS 13 0.0103
61 HAEMOTHORAX 29 0.0100
62 HAND DEFORMITY 131 0.0100
63 ARTERY DISSECTION 4 0.0097
64 BLOOD BICARBONATE DECREASED 18 0.0095
65 KLEBSIELLA TEST POSITIVE 6 0.0092
66 DUST ALLERGY 9 0.0092
67 HYPERTRANSAMINASAEMIA 62 0.0089
68 CAECITIS 4 0.0089
69 OVERLAP SYNDROME 6 0.0086
70 NEUROMUSCULAR BLOCK PROLONGED 3 0.0081
71 ABDOMINAL SEPSIS 7 0.0079
72 HYPERPHOSPHATAEMIA 17 0.0079
73 MEDIASTINAL MASS 3 0.0078
74 ADMINISTRATION SITE REACTION 3 0.0078
75 MULTI-ORGAN FAILURE 133 0.0077
76 AUTOIMMUNE DISORDER 74 0.0076
77 LIVE BIRTH 63 0.0075
78 RETINITIS 13 0.0075
79 TOTAL LUNG CAPACITY DECREASED 12 0.0075
80 LIVER INJURY 184 0.0075
81 PRESCRIBED OVERDOSE 145 0.0075
82 SYNOVITIS 135 0.0075
83 PERFORATION 6 0.0074
84 PULMONARY FIBROSIS 138 0.0072
85 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 4 0.0071
86 ELECTROENCEPHALOGRAM ABNORMAL 22 0.0070
87 BLOOD PHOSPHORUS INCREASED 19 0.0070
88 FEAR 184 0.0068
89 IRRITABLE BOWEL SYNDROME 145 0.0068
90 CONJUNCTIVITIS ALLERGIC 10 0.0067
91 FIBROADENOMA OF BREAST 3 0.0067
92 CLONUS 18 0.0066
93 LOWER LIMB FRACTURE 124 0.0064
94 OXYGEN SATURATION ABNORMAL 18 0.0063
95 BONE EROSION 22 0.0062
96 TOXIC EPIDERMAL NECROLYSIS 91 0.0060
97 SUPERFICIAL VEIN THROMBOSIS 5 0.0059
98 INJURY 414 0.0059
99 PERIPHERAL VENOUS DISEASE 24 0.0059
100 TYPE 2 DIABETES MELLITUS 197 0.0058
101 NEURITIS 9 0.0058
102 FEAR OF DEATH 13 0.0058
103 C-REACTIVE PROTEIN ABNORMAL 37 0.0058
104 BREAST CANCER STAGE III 37 0.0057
105 RENAL INJURY 169 0.0057
106 DELAYED GRAFT FUNCTION 4 0.0056
107 BLOOD GASES ABNORMAL 3 0.0056
108 GLOSSODYNIA 124 0.0055
109 CATARRH 5 0.0055
110 FINGER AMPUTATION 4 0.0054
111 JOINT ANKYLOSIS 3 0.0053
112 ACIDOSIS HYPERCHLORAEMIC 3 0.0051
113 PRODUCT PACKAGING CONFUSION 12 0.0049
114 ENTEROCOCCAL SEPSIS 4 0.0049
115 SPUTUM CULTURE POSITIVE 4 0.0049
116 SCIATICA 78 0.0049
117 VASOPLEGIA SYNDROME 8 0.0049
118 ANHEDONIA 128 0.0049
119 HYPERLACTACIDAEMIA 13 0.0048
120 GASTRIC DILATATION 8 0.0048
121 HYPOVOLAEMIA 28 0.0048
122 FIBROMYALGIA 114 0.0047
123 PRESCRIBED UNDERDOSE 92 0.0046
124 AORTIC STENOSIS 16 0.0046
125 PSORIATIC ARTHROPATHY 186 0.0046
126 WOUND INFECTION 50 0.0046
127 STEROID DEPENDENCE 4 0.0046
128 LUNG OPACITY 12 0.0045
129 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23 0.0045
130 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 9 0.0044
131 ANGIOPATHY 24 0.0043
132 SKIN NECROSIS 22 0.0042
133 CONTRAINDICATED PRODUCT ADMINISTERED 127 0.0042
134 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 16 0.0042
135 OEDEMA 226 0.0042
136 COLON NEOPLASM 4 0.0041
137 CONTINUOUS HAEMODIAFILTRATION 4 0.0041
138 FIBROCYSTIC BREAST DISEASE 3 0.0041
139 HYPERCHOLESTEROLAEMIA 39 0.0040
140 DEBRIDEMENT 3 0.0039
141 BLEPHAROSPASM 24 0.0038
142 BODY TEMPERATURE ABNORMAL 7 0.0038
143 SMALL INTESTINAL PERFORATION 7 0.0037
144 BLOOD IMMUNOGLOBULIN E INCREASED 9 0.0037
145 CARDIOGENIC SHOCK 53 0.0037
146 BLOOD URIC ACID INCREASED 21 0.0036
147 SYSTEMIC LUPUS ERYTHEMATOSUS 127 0.0036
148 IRON DEFICIENCY 16 0.0036
149 PROCEDURAL HYPOTENSION 3 0.0035
150 GRIP STRENGTH DECREASED 31 0.0035
151 RESPIRATORY SYMPTOM 10 0.0035
152 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 60 0.0035
153 LUNG HYPERINFLATION 3 0.0035
154 PORPHYRIA ACUTE 5 0.0035
155 WOUND 95 0.0034
156 LOWER RESPIRATORY TRACT INFECTION 153 0.0034
157 JOINT RANGE OF MOTION DECREASED 45 0.0034
158 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
159 PULSELESS ELECTRICAL ACTIVITY 14 0.0033
160 ESCHERICHIA TEST POSITIVE 4 0.0033
161 NORMOCHROMIC NORMOCYTIC ANAEMIA 10 0.0033
162 IMPAIRED HEALING 109 0.0033
163 BURSITIS 40 0.0033
164 FOETAL DEATH 17 0.0033
165 SHOCK HAEMORRHAGIC 26 0.0032
166 BLOOD CHOLESTEROL INCREASED 148 0.0032
167 LEFT VENTRICULAR DYSFUNCTION 21 0.0031
168 BLOOD CALCIUM DECREASED 35 0.0031
169 HYPOPHOSPHATAEMIA 23 0.0031
170 DISTRIBUTIVE SHOCK 7 0.0031
171 VENTRICULAR DYSFUNCTION 8 0.0031
172 FLUID INTAKE REDUCED 15 0.0030
173 HAEMANGIOMA OF LIVER 3 0.0030
174 LIP DRY 27 0.0030
175 VENTRICULAR FIBRILLATION 33 0.0030
176 SLEEP DISORDER 208 0.0029
177 ISCHAEMIC HEPATITIS 4 0.0029
178 BLOOD MAGNESIUM DECREASED 25 0.0029
179 BRASH SYNDROME 4 0.0028
180 BURNS SECOND DEGREE 5 0.0028
181 MYASTHENIA GRAVIS 23 0.0028
182 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 4 0.0028
183 THERAPY NON-RESPONDER 127 0.0028
184 FORCED EXPIRATORY VOLUME DECREASED 8 0.0028
185 LIVER DISORDER 123 0.0028
186 STOMATITIS 168 0.0028
187 MOBILITY DECREASED 198 0.0028
188 INCREASED BRONCHIAL SECRETION 7 0.0027
189 PULSE ABSENT 13 0.0027
190 SINUS NODE DYSFUNCTION 5 0.0027
191 GAIT INABILITY 91 0.0027
192 UNEVALUABLE EVENT 205 0.0027
193 INFUSION SITE REACTION 8 0.0027
194 EXTRAVASATION 11 0.0027
195 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 7 0.0027
196 POLYARTHRITIS 14 0.0027
197 THERAPEUTIC PRODUCT EFFECT DECREASED 117 0.0026
198 BLOOD PRESSURE DIASTOLIC INCREASED 12 0.0026
199 WALKING AID USER 17 0.0026
200 PRODUCT LABEL CONFUSION 15 0.0026
201 INCISION SITE PAIN 3 0.0026
202 BLISTER 143 0.0025
203 NAIL DISORDER 22 0.0025
204 BLOOD CALCIUM INCREASED 22 0.0025
205 INTRA-UTERINE DEATH 4 0.0025
206 ALLERGY TO CHEMICALS 3 0.0024
207 EXOSTOSIS 22 0.0024
208 AMPUTATION 3 0.0024
209 BREAST CANCER STAGE II 20 0.0024
210 ERYSIPELAS 12 0.0024
211 EMPHYSEMA 24 0.0024
212 ACIDOSIS 18 0.0024
213 HYPERCALCAEMIA 29 0.0023
214 HEPATITIS 60 0.0023
215 WHEEZING 139 0.0023
216 RECALLED PRODUCT 4 0.0023
217 PUPIL FIXED 4 0.0023
218 BLOOD TEST ABNORMAL 32 0.0023
219 APPENDICITIS 21 0.0022
220 BODY TEMPERATURE DECREASED 22 0.0022
221 HEPARIN-INDUCED THROMBOCYTOPENIA 11 0.0022
222 BRONCHIECTASIS 15 0.0022
223 PSEUDOMONAS INFECTION 19 0.0022
224 STATUS EPILEPTICUS 25 0.0022
225 NORMAL NEWBORN 12 0.0022
226 HYPERNATRAEMIA 11 0.0022
227 PERIPHERAL ISCHAEMIA 9 0.0022
228 URINE ABNORMALITY 10 0.0022
229 BLOOD PHOSPHORUS DECREASED 8 0.0022
230 VENTRICULAR HYPOKINESIA 7 0.0022
231 PERITONEAL HAEMORRHAGE 3 0.0022
232 ECHOCARDIOGRAM ABNORMAL 3 0.0021
233 ONYCHOMADESIS 9 0.0021
234 INFUSION RELATED REACTION 142 0.0021
235 TROPONIN INCREASED 16 0.0021
236 NEUROLOGICAL SYMPTOM 12 0.0021
237 OLIGURIA 13 0.0021
238 RENAL FAILURE 276 0.0021
239 THERAPEUTIC RESPONSE DECREASED 126 0.0021
240 RENAL IMPAIRMENT 173 0.0021
241 PULMONARY FUNCTION TEST DECREASED 9 0.0021
242 CARDIOPULMONARY FAILURE 8 0.0020
243 NODAL RHYTHM 3 0.0020
244 HIP ARTHROPLASTY 31 0.0020
245 DISABILITY 40 0.0020
246 HYPERTHERMIA MALIGNANT 3 0.0020
247 ROAD TRAFFIC ACCIDENT 84 0.0020
248 DRUG TOLERANCE 10 0.0020
249 HAEMODYNAMIC INSTABILITY 15 0.0020
250 INJECTION SITE NECROSIS 4 0.0020
251 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
252 NEUTROPENIC SEPSIS 14 0.0020
253 DRUG-INDUCED LIVER INJURY 61 0.0019
254 SPINAL STENOSIS 8 0.0019
255 IMMUNOSUPPRESSION 17 0.0019
256 LIVEDO RETICULARIS 4 0.0019
257 FOOT DEFORMITY 21 0.0019
258 RALES 11 0.0019
259 ADVERSE REACTION 25 0.0019
260 LUPUS-LIKE SYNDROME 17 0.0019
261 METABOLIC ALKALOSIS 3 0.0019
262 DISCOMFORT 114 0.0019
263 SINUSITIS 190 0.0019
264 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
265 ARTHROPATHY 102 0.0018
266 PLEURITIC PAIN 5 0.0018
267 JOINT SWELLING 218 0.0018
268 CALCINOSIS 4 0.0018
269 RASH PRURITIC 97 0.0018
270 ADENOCARCINOMA 4 0.0018
271 ENDOTRACHEAL INTUBATION 5 0.0018
272 PULMONARY ALVEOLAR HAEMORRHAGE 10 0.0018
273 FACE OEDEMA 30 0.0018
274 COLITIS ISCHAEMIC 12 0.0018
275 NEUROPATHY 3 0.0018
276 MATERNAL EXPOSURE DURING PREGNANCY 157 0.0018
277 SWELLING 164 0.0018
278 PREGNANCY 35 0.0017
279 PUSTULAR PSORIASIS 6 0.0017
280 DRUG INTOLERANCE 168 0.0017
281 ORGAN FAILURE 7 0.0017
282 BLOOD CHLORIDE INCREASED 3 0.0017
283 HEPATIC ENZYME INCREASED 118 0.0017
284 HYPOPNOEA 6 0.0017
285 SPINAL FUSION SURGERY 7 0.0017
286 EXTREMITY NECROSIS 3 0.0017
287 JAUNDICE CHOLESTATIC 6 0.0017
288 OBESITY 27 0.0017
289 RESPIRATORY FAILURE 123 0.0017
290 JUGULAR VEIN THROMBOSIS 3 0.0017
291 ASCITES 49 0.0017
292 ENTEROCOCCAL INFECTION 8 0.0017
293 GENERAL PHYSICAL HEALTH DETERIORATION 190 0.0016
294 PNEUMOTHORAX 26 0.0016
295 INTESTINAL ISCHAEMIA 9 0.0016
296 PNEUMOPERITONEUM 3 0.0016
297 MIGRAINE 155 0.0016
298 OPPORTUNISTIC INFECTION 3 0.0016
299 HYPERVOLAEMIA 8 0.0016
300 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
301 ACUTE PULMONARY OEDEMA 9 0.0016
302 VENOOCCLUSIVE DISEASE 4 0.0016
303 SYSTEMIC CANDIDA 4 0.0016
304 ENCEPHALOPATHY 39 0.0016
305 DYSPEPSIA 155 0.0016
306 PARKINSON'S DISEASE 4 0.0016
307 BLOOD PRESSURE DIASTOLIC ABNORMAL 4 0.0016
308 ADRENAL INSUFFICIENCY 19 0.0016
309 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 8 0.0016
310 RENAL FAILURE CHRONIC 12 0.0016
311 MULTIPLE ORGAN DYSFUNCTION SYNDROME 44 0.0016
312 LEUKOPENIA 77 0.0015
313 RED BLOOD CELL SEDIMENTATION RATE INCREASED 17 0.0015
314 RENAL FAILURE ACUTE 65 0.0015
315 NEPHROGENIC ANAEMIA 7 0.0015
316 DEVICE RELATED SEPSIS 3 0.0015
317 HEPATIC CIRRHOSIS 28 0.0015
318 HYPOCALCAEMIA 28 0.0015
319 CLOSTRIDIAL INFECTION 5 0.0015
320 MUSCULOSKELETAL STIFFNESS 129 0.0015
321 ASTHMA 166 0.0015
322 ASPIRATION 16 0.0015
323 CONJUNCTIVITIS 27 0.0015
324 RASH VESICULAR 7 0.0014
325 INFUSION SITE EXTRAVASATION 9 0.0014
326 TREATMENT FAILURE 118 0.0014
327 JOINT DISLOCATION 15 0.0014
328 CATHETER SITE ERYTHEMA 3 0.0014
329 ANAPHYLACTIC SHOCK 36 0.0014
330 VISUAL DISTURBANCE 8 0.0014
331 BACTERIAL INFECTION 26 0.0014
332 FACIAL PALSY 3 0.0014
333 PERIODONTITIS 3 0.0014
334 SPONDYLITIS 5 0.0014
335 ASPERGILLUS INFECTION 9 0.0014
336 ELECTROCARDIOGRAM T WAVE INVERSION 3 0.0014
337 STOMACH DISCOMFORT 7 0.0014
338 EMOTIONAL DISTRESS 164 0.0014
339 SHOCK 31 0.0013
340 CYTOKINE RELEASE SYNDROME 27 0.0013
341 BRAIN HERNIATION 4 0.0013
342 HYPERLIPIDAEMIA 16 0.0013
343 METABOLIC ENCEPHALOPATHY 4 0.0013
344 KNEE ARTHROPLASTY 28 0.0013
345 BLOOD LACTIC ACID INCREASED 7 0.0013
346 HYPERCAPNIA 4 0.0013
347 DELIRIUM 46 0.0013
348 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
349 FIBROSIS 4 0.0013
350 PLEURAL EFFUSION 79 0.0013
351 INTENTIONAL PRODUCT USE ISSUE 113 0.0013
352 RIGHT VENTRICULAR FAILURE 9 0.0013
353 MOUTH ULCERATION 27 0.0013
354 PULMONARY HAEMORRHAGE 10 0.0013
355 ARTERIOSCLEROSIS 12 0.0013
356 RHEUMATOID ARTHRITIS 144 0.0013
357 OBSTRUCTIVE AIRWAYS DISORDER 14 0.0013
358 HYPOTENSION 251 0.0012
359 TACHYPNOEA 17 0.0012
360 CUSHINGOID 4 0.0012
361 FULL BLOOD COUNT ABNORMAL 13 0.0012
362 SUDDEN DEATH 13 0.0012
363 PSYCHIATRIC SYMPTOM 9 0.0012
364 ELECTROLYTE IMBALANCE 14 0.0012
365 ILL-DEFINED DISORDER 73 0.0012
366 IRON DEFICIENCY ANAEMIA 11 0.0012
367 URTICARIA 199 0.0012
368 ACUTE RESPIRATORY DISTRESS SYNDROME 21 0.0012
369 LABYRINTHITIS 3 0.0012
370 WOUND DEHISCENCE 4 0.0012
371 APPENDICITIS PERFORATED 3 0.0012
372 GASTROINTESTINAL DISORDER 105 0.0012
373 ANURIA 10 0.0012
374 CARDIAC MURMUR 10 0.0012
375 URINE OUTPUT DECREASED 10 0.0011
376 COAGULOPATHY 19 0.0011
377 INJECTION SITE EXTRAVASATION 14 0.0011
378 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
379 OSTEOARTHRITIS 48 0.0011
380 AREFLEXIA 3 0.0011
381 ALCOHOL POISONING 3 0.0011
382 NIGHT SWEATS 36 0.0011
383 ANAESTHETIC COMPLICATION 3 0.0011
384 NEURALGIA 27 0.0011
385 HYPOXIA 39 0.0011
386 JOINT STIFFNESS 29 0.0011
387 LUNG DISORDER 54 0.0011
388 LUMBAR VERTEBRAL FRACTURE 5 0.0011
389 MOTOR DYSFUNCTION 11 0.0011
390 NECROSIS 6 0.0011
391 BLOOD UREA INCREASED 18 0.0011
392 NODULE 14 0.0011
393 LUNG CONSOLIDATION 3 0.0011
394 HEPATIC NECROSIS 4 0.0011
395 PULMONARY HYPERTENSION 22 0.0011
396 EAR INFECTION 28 0.0011
397 PNEUMATOSIS INTESTINALIS 3 0.0011
398 ANXIETY 295 0.0010
399 WRONG PRODUCT ADMINISTERED 7 0.0010
400 COMA SCALE ABNORMAL 3 0.0010
401 SINUS BRADYCARDIA 10 0.0010
402 METABOLIC ACIDOSIS 33 0.0010
403 HYPOALBUMINAEMIA 8 0.0010
404 BLOOD PRESSURE SYSTOLIC INCREASED 20 0.0010
405 LIVER FUNCTION TEST INCREASED 22 0.0010
406 RESPIRATORY ACIDOSIS 4 0.0010
407 PNEUMONIA FUNGAL 4 0.0010
408 GASTROINTESTINAL SOUNDS ABNORMAL 5 0.0010
409 ULCER 16 0.0010
410 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0010
411 CIRCULATORY COLLAPSE 17 0.0010
412 EXPOSURE DURING PREGNANCY 62 0.0010
413 CANDIDIASIS 4 0.0010
414 TRIGEMINAL NEURALGIA 4 0.0010
415 EAR PAIN 19 0.0010
416 DIASTOLIC DYSFUNCTION 3 0.0010
417 GAIT DISTURBANCE 186 0.0010
418 GENERALISED OEDEMA 12 0.0010
419 RESPIRATORY DISORDER 29 0.0010
420 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
421 HYPERTENSION 203 0.0010
422 BLOOD PRESSURE DIASTOLIC DECREASED 7 0.0009
423 SERUM FERRITIN INCREASED 5 0.0009
424 GOUT 17 0.0009
425 BRADYCARDIA 50 0.0009
426 ACUTE RESPIRATORY FAILURE 18 0.0009
427 CARDIAC ARREST 77 0.0009
428 END STAGE RENAL DISEASE 17 0.0009
429 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
430 BACK INJURY 10 0.0009
431 CONTUSION 88 0.0009
432 PROCEDURAL COMPLICATION 7 0.0009
433 ONYCHOMYCOSIS 4 0.0009
434 TUMOUR LYSIS SYNDROME 8 0.0009
435 VENTRICULAR TACHYCARDIA 15 0.0009
436 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
437 APNOEA 7 0.0009
438 CONFUSIONAL STATE 145 0.0009
439 TASTE DISORDER 18 0.0009
440 HYPERSENSITIVITY 164 0.0009
441 ECCHYMOSIS 6 0.0009
442 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 42 0.0009
443 SEPTIC SHOCK 38 0.0009
444 ISCHAEMIA 4 0.0009
445 PERIPHERAL SWELLING 134 0.0009
446 RHINITIS 7 0.0009
447 DRY MOUTH 70 0.0009
448 VASCULITIS 10 0.0009
449 NASOPHARYNGITIS 158 0.0009
450 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
451 EMBOLIC STROKE 3 0.0009
452 STAPHYLOCOCCAL INFECTION 28 0.0008
453 SINUS TACHYCARDIA 12 0.0008
454 DIVERTICULUM 6 0.0008
455 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
456 SPUTUM DISCOLOURED 8 0.0008
457 CYTOMEGALOVIRUS INFECTION 14 0.0008
458 INFECTION 121 0.0008
459 ABDOMINAL DISCOMFORT 139 0.0008
460 FLUID OVERLOAD 12 0.0008
461 TACHYCARDIA 73 0.0008
462 EPILEPSY 25 0.0008
463 IMMUNODEFICIENCY 12 0.0008
464 GENERAL SYMPTOM 6 0.0008
465 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
466 HYPERKALAEMIA 28 0.0008
467 SEPSIS 89 0.0008
468 CONDITION AGGRAVATED 242 0.0008
469 LUNG INFILTRATION 7 0.0008
470 PYREXIA 274 0.0008
471 MYOSITIS 7 0.0008
472 CEREBRAL ISCHAEMIA 4 0.0008
473 PERIPHERAL VASCULAR DISORDER 4 0.0008
474 LEUKOCYTOSIS 14 0.0008
475 POST PROCEDURAL HAEMORRHAGE 9 0.0008
476 EJECTION FRACTION DECREASED 12 0.0008
477 PERIORBITAL OEDEMA 4 0.0008
478 C-REACTIVE PROTEIN INCREASED 28 0.0008
479 ORAL INFECTION 3 0.0008
480 MALABSORPTION 4 0.0008
481 PRODUCT USE IN UNAPPROVED INDICATION 189 0.0008
482 MEDICATION ERROR 42 0.0008
483 HYPOAESTHESIA 113 0.0008
484 ARTERIOSPASM CORONARY 3 0.0007
485 MUSCLE HAEMORRHAGE 3 0.0007
486 BREAST MASS 5 0.0007
487 BLOOD POTASSIUM INCREASED 12 0.0007
488 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
489 BODY TEMPERATURE INCREASED 15 0.0007
490 SKIN ULCER 19 0.0007
491 PRODUCT USE ISSUE 138 0.0007
492 OESOPHAGITIS 8 0.0007
493 CHOLELITHIASIS 24 0.0007
494 ESCHERICHIA INFECTION 6 0.0007
495 OSTEOPOROSIS 30 0.0007
496 ALOPECIA 143 0.0007
497 ADVERSE EVENT 67 0.0007
498 CHOKING SENSATION 4 0.0007
499 WEIGHT INCREASED 162 0.0007
500 BLOOD PRESSURE DECREASED 48 0.0007
501 HAEMODIALYSIS 6 0.0007
502 RENAL TUBULAR NECROSIS 7 0.0007
503 PAIN IN EXTREMITY 210 0.0007
504 INTESTINAL PERFORATION 8 0.0007
505 BUNDLE BRANCH BLOCK LEFT 3 0.0007
506 AMNESIA 46 0.0007
507 PAIN 434 0.0007
508 FLATULENCE 40 0.0007
509 CARDIAC FAILURE CHRONIC 3 0.0007
510 PERONEAL NERVE PALSY 4 0.0007
511 ANOREXIA 9 0.0007
512 ABNORMAL SENSATION IN EYE 3 0.0007
513 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
514 PNEUMONIA 223 0.0007
515 RESPIRATORY DISTRESS 19 0.0007
516 ANAPHYLACTIC REACTION 38 0.0007
517 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
518 INITIAL INSOMNIA 7 0.0007
519 PHYSICAL DISABILITY 3 0.0007
520 BLOOD CREATINE INCREASED 3 0.0007
521 CHOLESTASIS 13 0.0007
522 RESPIRATORY RATE INCREASED 6 0.0007
523 OEDEMA PERIPHERAL 82 0.0007
524 TENDERNESS 7 0.0007
525 HYPOKALAEMIA 31 0.0007
526 PROTHROMBIN TIME PROLONGED 4 0.0007
527 MUSCULOSKELETAL PAIN 35 0.0007
528 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
529 CHROMATURIA 15 0.0007
530 PAROSMIA 5 0.0007
531 INFLAMMATION 34 0.0007
532 INSOMNIA 175 0.0007
533 ACCIDENTAL OVERDOSE 24 0.0007
534 ABDOMINAL PAIN UPPER 135 0.0007
535 ACUTE GRAFT VERSUS HOST DISEASE 3 0.0007
536 CHEST PAIN 121 0.0007
537 GRAND MAL CONVULSION 6 0.0006
538 DEVICE RELATED INFECTION 10 0.0006
539 THROMBOSIS 52 0.0006
540 CONGENITAL ANOMALY 5 0.0006
541 TOOTH EXTRACTION 8 0.0006
542 DEFORMITY 6 0.0006
543 CARDIAC TAMPONADE 3 0.0006
544 HEPATIC FAILURE 19 0.0006
545 GINGIVAL PAIN 5 0.0006
546 APHAGIA 3 0.0006
547 UNRESPONSIVE TO STIMULI 16 0.0006
548 ABDOMINAL PAIN 144 0.0006
549 PULMONARY EMBOLISM 58 0.0006
550 HAEMOPTYSIS 17 0.0006
551 NASAL POLYPS 3 0.0006
552 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
553 UPPER RESPIRATORY TRACT INFECTION 28 0.0006
554 ABDOMINAL TENDERNESS 3 0.0006
555 HEMIPLEGIA 5 0.0006
556 PNEUMONIA ASPIRATION 15 0.0006
557 BRAIN INJURY 6 0.0006
558 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 31 0.0006
559 OSTEOPENIA 9 0.0006
560 HYPOTHERMIA 6 0.0006
561 INTENTIONAL OVERDOSE 38 0.0006
562 PATHOLOGICAL FRACTURE 3 0.0006
563 DYSLIPIDAEMIA 3 0.0006
564 EPISTAXIS 44 0.0006
565 MUSCLE RIGIDITY 7 0.0006
566 ENDOCARDITIS 3 0.0006
567 CACHEXIA 3 0.0006
568 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 15 0.0006
569 HYPERBILIRUBINAEMIA 6 0.0006
570 WEIGHT FLUCTUATION 6 0.0006
571 PARTIAL SEIZURES 3 0.0006
572 CYANOSIS 9 0.0006
573 EOSINOPHILIA 10 0.0006
574 CARDIOMEGALY 7 0.0006
575 DECREASED APPETITE 132 0.0006
576 DEPRESSION 129 0.0006
577 BRONCHOSPASM 8 0.0006
578 ABDOMINAL DISTENSION 58 0.0006
579 ACUTE KIDNEY INJURY 85 0.0006
580 BLOOD CREATININE INCREASED 36 0.0006
581 HYDROCEPHALUS 3 0.0006
582 CARDIO-RESPIRATORY ARREST 23 0.0005
583 SPINAL FRACTURE 11 0.0005
584 GENERALISED TONIC-CLONIC SEIZURE 9 0.0005
585 HEART RATE ABNORMAL 3 0.0005
586 MALNUTRITION 6 0.0005
587 PULMONARY OEDEMA 24 0.0005
588 ADVERSE DRUG REACTION 48 0.0005
589 LACERATION 5 0.0005
590 ORAL CANDIDIASIS 7 0.0005
591 HYPERGLYCAEMIA 19 0.0005
592 POST PROCEDURAL COMPLICATION 10 0.0005
593 HAEMOLYSIS 4 0.0005
594 ATELECTASIS 5 0.0005
595 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
596 METABOLIC DISORDER 3 0.0005
597 HYPONATRAEMIA 29 0.0005
598 PELVIC FRACTURE 4 0.0005
599 FEBRILE NEUTROPENIA 34 0.0005
600 TORSADE DE POINTES 4 0.0005
601 COELIAC DISEASE 5 0.0005
602 ARTERIAL OCCLUSIVE DISEASE 4 0.0005
603 ARTHRITIS 40 0.0005
604 DEEP VEIN THROMBOSIS 33 0.0005
605 BLOOD IRON DECREASED 6 0.0005
606 BACTERAEMIA 6 0.0005
607 HAEMATOCRIT DECREASED 10 0.0005
608 MENTAL STATUS CHANGES 14 0.0005
609 BLADDER DISORDER 5 0.0005
610 COLITIS 19 0.0005
611 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
612 GANGRENE 3 0.0005
613 HAEMATURIA 17 0.0005
614 LYMPHOPENIA 7 0.0005
615 PAIN IN JAW 14 0.0005
616 BONE DISORDER 9 0.0005
617 FOETAL GROWTH RESTRICTION 3 0.0005
618 NO THERAPEUTIC RESPONSE 6 0.0005
619 RESPIRATORY DEPRESSION 6 0.0005
620 SUBDURAL HAEMATOMA 7 0.0005
621 POLYURIA 4 0.0005
622 SMALL INTESTINAL OBSTRUCTION 6 0.0005
623 TENDON RUPTURE 6 0.0005
624 PIGMENTATION DISORDER 3 0.0005
625 ILEUS 6 0.0005
626 ATRIAL FIBRILLATION 47 0.0005
627 VENTRICULAR EXTRASYSTOLES 5 0.0005
628 TUBULOINTERSTITIAL NEPHRITIS 9 0.0005
629 NERVOUSNESS 25 0.0005
630 VOMITING 224 0.0005
631 BRAIN OEDEMA 6 0.0005
632 CARDIOMYOPATHY 7 0.0005
633 INCONTINENCE 5 0.0005
634 HAEMORRHAGE INTRACRANIAL 7 0.0005
635 VITAMIN D DECREASED 4 0.0005
636 FEELING COLD 13 0.0005
637 MUSCULAR WEAKNESS 53 0.0005
638 BLOOD POTASSIUM DECREASED 14 0.0005
639 PSYCHOLOGICAL TRAUMA 4 0.0005
640 HEPATITIS ACUTE 3 0.0005
641 ANAEMIA 88 0.0005
642 HAEMORRHOIDS 9 0.0005
643 PRODUCTIVE COUGH 22 0.0005
644 METASTASES TO LIVER 8 0.0005
645 LYMPHOCYTE COUNT DECREASED 8 0.0005
646 NAUSEA 358 0.0005
647 DYSPNOEA 254 0.0004
648 DIABETES MELLITUS 34 0.0004
649 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
650 PNEUMONITIS 12 0.0004
651 FEELING HOT 27 0.0004
652 MYOCARDIAL ISCHAEMIA 5 0.0004
653 HYPOTHYROIDISM 14 0.0004
654 LOSS OF CONSCIOUSNESS 56 0.0004
655 JOINT EFFUSION 3 0.0004
656 PERICARDIAL EFFUSION 10 0.0004
657 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
658 HYPOMAGNESAEMIA 6 0.0004
659 BACK DISORDER 7 0.0004
660 HEART RATE DECREASED 15 0.0004
661 FLANK PAIN 4 0.0004
662 METASTASES TO BONE 7 0.0004
663 DEVICE OCCLUSION 6 0.0004
664 HAEMATOMA 11 0.0004
665 HAND FRACTURE 3 0.0004
666 ARTHRALGIA 176 0.0004
667 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
668 HEMIPARESIS 7 0.0004
669 NECK PAIN 23 0.0004
670 HAEMOGLOBIN DECREASED 42 0.0004
671 FREQUENT BOWEL MOVEMENTS 11 0.0004
672 PALLOR 11 0.0004
673 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
674 OSTEONECROSIS 13 0.0004
675 FLUID RETENTION 20 0.0004
676 HYPERTHERMIA 3 0.0004
677 OXYGEN SATURATION DECREASED 22 0.0004
678 NEUTROPHIL COUNT INCREASED 4 0.0004
679 RIB FRACTURE 8 0.0004
680 MUSCULOSKELETAL CHEST PAIN 6 0.0004
681 PERITONITIS 8 0.0004
682 OFF LABEL USE 336 0.0004
683 PETECHIAE 4 0.0004
684 BLOOD ALBUMIN DECREASED 3 0.0004
685 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
686 BLOOD PRESSURE FLUCTUATION 9 0.0004
687 IMPAIRED WORK ABILITY 8 0.0004
688 CARDIAC FAILURE 30 0.0004
689 BLOOD PRESSURE INCREASED 57 0.0004
690 QUALITY OF LIFE DECREASED 5 0.0004
691 DYSPNOEA EXERTIONAL 14 0.0004
692 PRURITUS 142 0.0004
693 THROMBOCYTOPENIA 41 0.0004
694 INTENTIONAL PRODUCT MISUSE 32 0.0004
695 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 26 0.0004
696 PERIPHERAL COLDNESS 5 0.0004
697 SEIZURE 42 0.0004
698 HAEMORRHAGE 38 0.0004
699 RESPIRATORY ARREST 10 0.0004
700 DENTAL CARIES 4 0.0004
701 EMBOLISM 3 0.0004
702 MALAISE 158 0.0004
703 GASTROOESOPHAGEAL REFLUX DISEASE 29 0.0004
704 MUSCLE SPASMS 66 0.0004
705 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
706 CHILLS 42 0.0004
707 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
708 BLINDNESS UNILATERAL 5 0.0004
709 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
710 MITRAL VALVE INCOMPETENCE 4 0.0004
711 CARDIAC DISORDER 33 0.0004
712 SWOLLEN TONGUE 11 0.0004
713 FACIAL PARALYSIS 3 0.0004
714 DERMATITIS CONTACT 4 0.0004
715 RECTAL HAEMORRHAGE 15 0.0003
716 RASH 152 0.0003
717 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
718 BONE MARROW FAILURE 7 0.0003
719 MUCOSAL INFLAMMATION 9 0.0003
720 CEREBROVASCULAR ACCIDENT 57 0.0003
721 CHOLECYSTITIS 4 0.0003
722 CEREBRAL HAEMORRHAGE 12 0.0003
723 MACULAR DEGENERATION 4 0.0003
724 NEPHROLITHIASIS 15 0.0003
725 DIZZINESS 163 0.0003
726 ABASIA 8 0.0003
727 DRUG INEFFECTIVE 425 0.0003
728 SECRETION DISCHARGE 4 0.0003
729 NEUTROPHIL COUNT DECREASED 13 0.0003
730 BLOOD SODIUM DECREASED 6 0.0003
731 ARRHYTHMIA 15 0.0003
732 MUSCLE ATROPHY 4 0.0003
733 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
734 FEELING JITTERY 6 0.0003
735 PREMATURE DELIVERY 5 0.0003
736 HEPATIC CYTOLYSIS 4 0.0003
737 WEIGHT DECREASED 87 0.0003
738 INFUSION SITE PAIN 4 0.0003
739 LIVER FUNCTION TEST ABNORMAL 9 0.0003
740 HYPOGLYCAEMIA 15 0.0003
741 NEEDLE ISSUE 9 0.0003
742 HIATUS HERNIA 4 0.0003
743 HAEMATOCHEZIA 17 0.0003
744 PLATELET COUNT INCREASED 4 0.0003
745 MEMORY IMPAIRMENT 42 0.0003
746 BACK PAIN 71 0.0003
747 PULMONARY CONGESTION 4 0.0003
748 BLOOD PRESSURE ABNORMAL 6 0.0003
749 ASPARTATE AMINOTRANSFERASE INCREASED 16 0.0003
750 HYPOTONIA 3 0.0003
751 BRONCHITIS 22 0.0003
752 TOXICITY TO VARIOUS AGENTS 50 0.0003
753 ASTHENIA 111 0.0003
754 DRUG TOXICITY 4 0.0003
755 ACUTE HEPATIC FAILURE 4 0.0003
756 DYSARTHRIA 11 0.0003
757 LIMB DISCOMFORT 9 0.0003
758 COLITIS ULCERATIVE 13 0.0003
759 MUSCULOSKELETAL DISCOMFORT 5 0.0003
760 HEADACHE 181 0.0003
761 DIARRHOEA 186 0.0003
762 RHABDOMYOLYSIS 12 0.0003
763 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
764 ORTHOSTATIC HYPOTENSION 5 0.0003
765 COORDINATION ABNORMAL 4 0.0003
766 MALIGNANT NEOPLASM PROGRESSION 29 0.0003
767 SOMNOLENCE 57 0.0003
768 DIALYSIS 4 0.0003
769 EATING DISORDER 6 0.0003
770 PARALYSIS 4 0.0003
771 LACTIC ACIDOSIS 9 0.0003
772 ABNORMAL BEHAVIOUR 11 0.0003
773 OSTEOMYELITIS 5 0.0003
774 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
775 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 15 0.0003
776 BONE PAIN 16 0.0003
777 GASTROINTESTINAL PAIN 3 0.0003
778 DYSKINESIA 11 0.0003
779 RASH MACULO-PAPULAR 6 0.0003
780 DYSGEUSIA 20 0.0003
781 PULMONARY MASS 4 0.0003
782 NEPHROPATHY TOXIC 3 0.0003
783 FATIGUE 208 0.0003
784 CONSTIPATION 58 0.0003
785 ERYTHEMA 54 0.0003
786 CHOLECYSTECTOMY 3 0.0003
787 CONVULSION 15 0.0003
788 SLEEP APNOEA SYNDROME 5 0.0003
789 MYOCARDITIS 3 0.0003
790 PARAESTHESIA 41 0.0003
791 PHARYNGEAL OEDEMA 4 0.0003
792 BLOOD BILIRUBIN INCREASED 7 0.0003
793 LYMPHOMA 4 0.0003
794 CAESAREAN SECTION 3 0.0003
795 LUNG INFECTION 4 0.0003
796 BASAL CELL CARCINOMA 4 0.0003
797 SKIN LESION 7 0.0003
798 MYOCLONUS 3 0.0003
799 ACCIDENT 3 0.0003
800 RASH ERYTHEMATOUS 12 0.0003
801 SENSORY DISTURBANCE 4 0.0002
802 CARDIAC FAILURE CONGESTIVE 20 0.0002
803 DEHYDRATION 33 0.0002
804 PRODUCT ADMINISTRATION ERROR 5 0.0002
805 NOCTURIA 3 0.0002
806 RESTLESSNESS 9 0.0002
807 THROAT IRRITATION 11 0.0002
808 CYTOPENIA 3 0.0002
809 DRUG LEVEL INCREASED 4 0.0002
810 TREMOR 40 0.0002
811 ABDOMINAL PAIN LOWER 6 0.0002
812 HAEMATEMESIS 6 0.0002
813 CATARACT 14 0.0002
814 PREMATURE BABY 7 0.0002
815 NIGHTMARE 8 0.0002
816 CORONARY ARTERY DISEASE 7 0.0002
817 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
818 COMA 11 0.0002
819 PALPITATIONS 27 0.0002
820 DEATH 198 0.0002
821 INTERVERTEBRAL DISC PROTRUSION 5 0.0002
822 DISEASE PROGRESSION 27 0.0002
823 GASTRITIS 6 0.0002
824 EMOTIONAL DISORDER 7 0.0002
825 ANGIOEDEMA 10 0.0002
826 FEMUR FRACTURE 7 0.0002
827 HEAD DISCOMFORT 4 0.0002
828 DRUG ERUPTION 4 0.0002
829 PLATELET COUNT DECREASED 24 0.0002
830 STEVENS-JOHNSON SYNDROME 5 0.0002
831 ISCHAEMIC STROKE 4 0.0002
832 HEART RATE INCREASED 22 0.0002
833 GASTROENTERITIS VIRAL 4 0.0002
834 SYNCOPE 22 0.0002
835 VISUAL IMPAIRMENT 27 0.0002
836 SKIN DISCOLOURATION 10 0.0002
837 ORAL DISCOMFORT 3 0.0002
838 MASS 3 0.0002
839 MIDDLE INSOMNIA 4 0.0002
840 PHOTOPHOBIA 4 0.0002
841 BLOOD URINE PRESENT 4 0.0002
842 COUGH 59 0.0002
843 IMPAIRED QUALITY OF LIFE 3 0.0002
844 BLOOD CREATINE PHOSPHOKINASE INCREASED 6 0.0002
845 PANCREATITIS 11 0.0002
846 MENTAL DISORDER 9 0.0002
847 GASTROENTERITIS 3 0.0002
848 ORAL HERPES 4 0.0002
849 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
850 SINUS DISORDER 4 0.0002
851 HOSPITALISATION 31 0.0002
852 BLOOD COUNT ABNORMAL 3 0.0002
853 CARDIOVASCULAR DISORDER 5 0.0002
854 DRUG DISPENSING ERROR 3 0.0002
855 HYPOPHAGIA 5 0.0002
856 UNDERDOSE 14 0.0002
857 HERPES ZOSTER 11 0.0002
858 PRODUCT QUALITY ISSUE 26 0.0002
859 MYOCARDIAL INFARCTION 33 0.0002
860 JOINT INJURY 4 0.0002
861 HIP FRACTURE 6 0.0002
862 JAUNDICE 5 0.0002
863 PRURITUS GENERALISED 4 0.0002
864 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
865 LIMB INJURY 5 0.0002
866 PSORIASIS 24 0.0002
867 PRODUCT PRESCRIBING ISSUE 4 0.0002
868 FALL 61 0.0002
869 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
870 DRUG INTERACTION 29 0.0002
871 MELAENA 4 0.0002
872 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
873 ORAL PAIN 4 0.0002
874 FLUSHING 18 0.0002
875 COVID-19 31 0.0002
876 DRUG EXPOSURE DURING PREGNANCY 6 0.0002
877 URINARY TRACT INFECTION 30 0.0002
878 CHEST DISCOMFORT 18 0.0002
879 ANGINA PECTORIS 5 0.0002
880 TINNITUS 8 0.0002
881 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
882 LOCAL SWELLING 3 0.0002
883 BLINDNESS 7 0.0002
884 RASH MACULAR 6 0.0002
885 DYSSTASIA 5 0.0002
886 COLD SWEAT 3 0.0002
887 INFLUENZA LIKE ILLNESS 14 0.0002
888 SWELLING FACE 11 0.0002
889 VISION BLURRED 23 0.0002
890 OVERDOSE 36 0.0002
891 CRYING 6 0.0002
892 MENTAL IMPAIRMENT 4 0.0002
893 VERTIGO 10 0.0002
894 CEREBRAL INFARCTION 4 0.0002
895 AGITATION 12 0.0002
896 INJECTION SITE RASH 5 0.0002
897 OSTEONECROSIS OF JAW 4 0.0002
898 PANCYTOPENIA 9 0.0002
899 AGEUSIA 4 0.0002
900 INTESTINAL OBSTRUCTION 6 0.0002
901 FOOT FRACTURE 3 0.0002
902 GASTRIC ULCER 3 0.0002
903 CYSTITIS 5 0.0002
904 SKIN EXFOLIATION 13 0.0002
905 DIPLOPIA 4 0.0002
906 SPEECH DISORDER 8 0.0002
907 INFLUENZA 17 0.0002
908 VISUAL ACUITY REDUCED 5 0.0002
909 INJURY ASSOCIATED WITH DEVICE 3 0.0001
910 MYALGIA 25 0.0001
911 DIVERTICULITIS 4 0.0001
912 POLLAKIURIA 6 0.0001
913 EYE PAIN 8 0.0001
914 RED BLOOD CELL COUNT DECREASED 4 0.0001
915 INCORRECT ROUTE OF DRUG ADMINISTRATION 5 0.0001
916 NEUTROPENIA 19 0.0001
917 FAECES DISCOLOURED 3 0.0001
918 NASAL CONGESTION 8 0.0001
919 ACUTE MYOCARDIAL INFARCTION 4 0.0001
920 LABORATORY TEST ABNORMAL 4 0.0001
921 URINARY INCONTINENCE 4 0.0001
922 HEPATOTOXICITY 3 0.0001
923 HEPATIC FUNCTION ABNORMAL 5 0.0001
924 ECZEMA 7 0.0001
925 APHASIA 4 0.0001
926 LACRIMATION INCREASED 4 0.0001
927 DRUG ADMINISTRATION ERROR 4 0.0001
928 NERVOUS SYSTEM DISORDER 4 0.0001
929 TREATMENT NONCOMPLIANCE 7 0.0001
930 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
931 OCULAR HYPERAEMIA 6 0.0001
932 DISORIENTATION 5 0.0001
933 ABORTION SPONTANEOUS 5 0.0001
934 PRESYNCOPE 3 0.0001
935 LETHARGY 7 0.0001
936 EYE DISORDER 4 0.0001
937 VIRAL INFECTION 4 0.0001
938 LIP SWELLING 4 0.0001
939 FUNGAL INFECTION 4 0.0001
940 URINARY RETENTION 4 0.0001
941 NEOPLASM MALIGNANT 8 0.0001
942 HOT FLUSH 9 0.0001
943 CELLULITIS 6 0.0001
944 CHRONIC KIDNEY DISEASE 9 0.0001
945 BLOOD GLUCOSE INCREASED 22 0.0001
946 DYSPHAGIA 11 0.0001
947 NEOPLASM PROGRESSION 4 0.0001
948 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
949 PANIC ATTACK 4 0.0001
950 ABNORMAL DREAMS 3 0.0001
951 FEELING ABNORMAL 26 0.0001
952 DEMENTIA 3 0.0001
953 HYPERSOMNIA 3 0.0001
954 BALANCE DISORDER 9 0.0001
955 HYPERHIDROSIS 13 0.0001
956 SUICIDE ATTEMPT 6 0.0001
957 BONE DENSITY DECREASED 3 0.0001
958 DRUG EFFECT DECREASED 5 0.0001
959 ACNE 7 0.0001
960 EXPIRED PRODUCT ADMINISTERED 3 0.0001
961 GASTRIC DISORDER 3 0.0001
962 EYE IRRITATION 5 0.0001
963 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
964 BURNING SENSATION 6 0.0001
965 DYSPHONIA 5 0.0001
966 LYMPHADENOPATHY 3 0.0001
967 NEUROPATHY PERIPHERAL 8 0.0001
968 BLOOD GLUCOSE DECREASED 4 0.0001
969 INTERSTITIAL LUNG DISEASE 4 0.0001
970 DRY EYE 4 0.0001
971 HALLUCINATION 6 0.0001
972 RHINORRHOEA 5 0.0001
973 INJECTION SITE HAEMORRHAGE 6 0.0001
974 DISTURBANCE IN ATTENTION 4 0.0001
975 LUNG NEOPLASM MALIGNANT 3 0.0001
976 INJECTION SITE ERYTHEMA 9 0.0001
977 HYPOACUSIS 3 0.0001
978 DISEASE RECURRENCE 3 0.0001
979 MULTIPLE SCLEROSIS 3 0.0001
980 NO ADVERSE EVENT 11 0.0001
981 DEVICE DIFFICULT TO USE 4 0.0001
982 INJECTION SITE PAIN 18 0.0001
983 DEPRESSED MOOD 3 0.0001
984 ILLNESS 5 0.0000
985 INCORRECT DOSE ADMINISTERED 10 0.0000
986 INJECTION SITE REACTION 3 0.0000
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
988 INJECTION SITE SWELLING 3 0.0000
989 DRY SKIN 5 0.0000
990 COMPLETED SUICIDE 3 0.0000
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
992 DEVICE ISSUE 3 0.0000
993 BREAST CANCER 3 0.0000
994 PRODUCT DOSE OMISSION ISSUE 9 0.0000